Daniel Carlat, MD.
Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.
Dr. Puzantian and Dr. Carlat have disclosed that they have no relevant relationships or financial interests in any commercial company pertaining to the information provided in this book.
Dr. Puzantian and Dr. Carlat have disclosed that they have no relevant relationships or financial interests in any commercial company pertaining to the information provided in this book.
Dr. Puzantian and Dr. Carlat have disclosed that they have no relevant relationships or financial interests in any commercial company pertaining to the information provided in this book.
Dr. Puzantian and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Dr. Puzantian and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Dr. Puzantian and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Dr. Aiken, Dr. Feder, and Dr. Carlat have no relevant financial relationship(s) with ineligible companies to disclose.
Dr. Aiken, Dr. Feder, and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity. have no relevant financial relationship(s) with ineligible companies to disclose.
Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report.
Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
